MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast - Episode Library
  • Patient Community Day at ECTRIMS 2025
  • Multiple Sclerosis in 2025 – Key Developments to Date
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us

Tagged Stem cells

neural stem cell

Neural Stem Cell Transplantation for Progressive MS

MStranslate
March 28, 2023
Research, Stem Cells, Treatments
1 Comment
Research Summary: Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study The treatment of...
AHSCT

Real World Application of AHSCT in MS

MStranslate
December 22, 2021
Research, Stem Cells, Treatments
Written by Brett Drummond (MStranslate co-founder), in collaboration with Joey Lambert (MStranslate intern) Autologous haematopoietic stem cell...
research update

Multiple Sclerosis Research Update – December 2020

MStranslate
December 15, 2020
Progressive MS, Research, Stem Cells, Treatments
With the end of 2020 approaching (I don’t think anyone is going to miss it), we thought we would try out a new style of research update. ...
mesenchymal stem cell

Mesenchymal Stem Cell Trial for Multiple Sclerosis

MStranslate
February 2, 2020
Conferences, Dr Travis Stiles, ECTRIMS, Stem Cells, Treatments
EXCLUSIVE INTERVIEW At ECTRIMS Congress 2019, we had the privilege of interviewing Prof. Dimitrios Karussis (Neurologist, Hadassah Hospital) about...
AHSCT

BEAT-MS Trial to Compare AHSCT to MS Treatments

MStranslate
January 14, 2020
Research, Stem Cells, Treatments
Over recent years, we have seen a large expansion in the number of available treatments for people living with relapsing-remitting multiple sclerosis...
ECTRIMS 2019

ECTRIMS 2019: Final Thoughts From Stockholm

MStranslate
September 13, 2019
Dr Travis Stiles, ECTRIMS, Research
ECTRIMS 2019 has officially ended.  It is safe to say that it was a huge three days and I am exhausted!  I really hope that you have enjoyed the...
stem cells

Stem Cells in Hair Follicles Show Myelin Repair Potential

MStranslate
April 30, 2019
Remyelination, Research, Stem Cells
Research Summary: CD34 defines melanocyte stem cell subpopulations with distinct regenerative properties Myelin repair or remyelination is...
HSCT

HSCT Trial Shows Positive Results for RRMS

MStranslate
February 19, 2019
Research, Stem Cells, Treatments
2 Comments
Research Summary: Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression...
AHSCT

Multiple Sclerosis Treatment Overview: AHSCT

MStranslate
June 13, 2017
Stem Cells, Treatments
1 Comment
Recently, I’ve had the pleasure of talking to a number of different local multiple sclerosis support groups about multiple sclerosis (MS) and MS...
HALT-MS

HALT-MS: Five Year Study Results

MStranslate
February 2, 2017
Research, Stem Cells, Treatments
Research Summary: High dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS The 5 year results of the HALT-MS trial were...
  1. 1
  2. 2

Recent Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Recent Comments

  • FDA Decision On Tolebrutinib - MStranslate on Multiple Sclerosis in 2025 – Key Developments to Date
  • Treatment With Gut Bacteria Shows Benefits In New Study on Gut Bacteria in People Living with RRMS
  • Community Q&A: COVID-19 Vaccines & Multiple Sclerosis on Community Q&A: The Blood-Brain Barrier
  • Community Q&A: Why Don't We Have A Multiple Sclerosis Cure? on Community Q&A: COVID-19 Vaccines & MS
  • Tim Little on FAKE NEWS ALERT: COVID Vaccines & MS

Calendar

March 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
« Jan    

Archives

Categories

Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.